Skip to main content
SpringerLink
Log in
Book cover

Vanadium Compounds: Biochemical and Therapeutic Applications

  • Book
  • © 1995

Overview

Editors:
  1. Ashok K. Srivastava

    1. Centre de Recherche, Hotel-Dieu de Montreal, Montreal, Canada

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Jean-Louis Chiasson

    1. Centre de Recherche, Hotel-Dieu de Montreal, Montreal, Canada

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Developments in Molecular and Cellular Biochemistry (DMCB, volume 16)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (30 chapters)

  1. Front Matter

    Pages i-1
    Download chapter PDF

  2. Chemistry

    1. Front Matter

      Pages 3-3
      Download chapter PDF

    2. The chemistry of peroxovanadium compounds relevant to insulin mimesis

      • Alan Shaver, Jesse B. Ng, David A. Hall, Barry I. Posner
      Pages 5-15

    3. Vanadium chemistry and biochemistry of relevance for use of vanadium compounds as antidiabetic agents

      • Debbie C. Crans, Mohammed Mahroof-Tahir, Anastasios D. Keramidas
      Pages 17-24

    4. Peroxo heteroligand vanadates(V): Synthesis, spectra-structure relationships, and stability toward decomposition

      • Cirila Djordjevic, Nikola Vuletic, Myunghi Lee Renslo, Bruce C. Puryear, Ramin Alimard
      Pages 25-29

    5. Chemically and photochemically initiated DNA cleavage by an insulin-mimetic bisperoxovanadium complex

      • Catharina Hiort, Jerry Goodisman, James C. Dabrowiak
      Pages 31-36

  3. Biochemical and Physiological Studies

    1. Front Matter

      Pages 37-37
      Download chapter PDF

    2. Insulin-like actions of vanadate are mediated in an insulin-receptor-independent manner via non-receptor protein tyrosine kinases and protein phosphotyrosine phosphatases

      • Yoram Shechter, Jingping Li, Joseph Meyerovitch, Dov Gefel, Rafael Bruck, Gerard Elberg et al.
      Pages 39-47

    3. Peroxovanadium compounds: Biological actions and mechanism of insulin-mimesis

      • A. Paul Bevan, Paul G. Drake, Jean-Francois Yale, Alan Shaver, Barry I. Posner
      Pages 49-58

    4. Unique and selective mitogenic effects of vanadate on SV40-transformed cells

      • Hanlin Wang, Robert E. Scott
      Pages 59-67

    5. Vanadium salts stimulate mitogen-activated protein (MAP) kinases and ribosomal S6 kinases

      • Sanjay K. Pandey, Jean-Louis Chiasson, Ashok K. Srivastava
      Pages 69-78

    6. Protective effect of vanadate on oxyradical-induced changes in isolated perfused heart

      • Taku Matsubara, Sorin Musat-Marcu, Hara P. Misra, Naranjan S. Dhalla
      Pages 79-85

    7. In vivo effects of vanadate on hepatic glycogen metabolizing and lipogenic enzymes in insulin-dependent and insulin-resistant diabetic animals

      • Ramji L. Khandelwal, Subbiah Pugazhenthi
      Pages 87-94

    8. The relationship between insulin and vanadium metabolism in insulin target tissues

      • Frederick G. Hamel, William C. Duckworth
      Pages 95-102

    9. Modulation of insulin action by vanadate: evidence of a role for phosphotyrosine phosphatase activity to alter cellular signaling

      • I. G. Fantus, G. Deragon, R. Lai, S. Tang
      Pages 103-112

    10. Reversal of defective G-proteins and adenylyl cyclase/cAMP signal transduction in diabetic rats by vanadyl sulphate therapy

      • Madhu B. Anand-Srivastava, John H. McNeill, Xiao-Ping Yang
      Pages 113-119

    11. Effects of vanadate on the expression of genes involved in fuel homeostasis in animal models of Type I and Type II diabetes

      • S. M. Brichard
      Pages 121-124

    12. Decrease in protein tyrosine phosphatase activities in vanadate-treated obese Zucker (fa/fa) rat liver

      • Subbiah Pugazhenthi, Feridoon Tanha, Bruce Dahl, Ramji L. Khandelwal
      Pages 125-129

    13. Evidence for selective effects of vanadium on adipose cell metabolism involving actions on cAMP-dependent protein kinase

      • Roger W. Brownsey, Gordon W. Dong
      Pages 131-137

    14. The enhancement by pervanadate of tyrosine phosphorylation on prostatic proteins occurs through the inhibition of membrane-associated tyrosine phosphatases

      • Martin Boissonneault, Alcide Chapdelaine, Simone Chevalier
      Pages 139-144
Back to top

Keywords

Editors and Affiliations

  • Centre de Recherche, Hotel-Dieu de Montreal, Montreal, Canada

    Ashok K. Srivastava, Jean-Louis Chiasson

Bibliographic Information

  • Book Title: Vanadium Compounds: Biochemical and Therapeutic Applications

  • Editors: Ashok K. Srivastava, Jean-Louis Chiasson

  • Series Title: Developments in Molecular and Cellular Biochemistry

  • DOI: https://doi.org/10.1007/978-1-4613-1251-2

  • Publisher: Springer New York, NY

  • eBook Packages: Springer Book Archive

  • Copyright Information: Kluwer Academic Publishers 1995

  • Hardcover ISBN: 978-0-7923-3762-1Published: 30 April 1996

  • eBook ISBN: 978-1-4613-1251-2Published: 06 December 2012

  • Edition Number: 1

  • Number of Pages: VI, 246

  • Number of Illustrations: 5 b/w illustrations

  • Topics: Endocrinology, Diabetes, Medical Biochemistry

Publish with us

Policies and ethics

Back to top

Search

Navigation